✦ LIBER ✦

Prostate-Specific Antigen Density Predicts Adverse Pathology and Increased Risk of Biochemical Failure

✍ Scribed by Mohamed H. Radwan; Yan Yan; Jason R. Luly; Robert S. Figenshau; Steven B. Brandes; Sam B. Bhayani; Arnold D. Bullock; Ye Liefu; Gerald L. Andriole; Adam S. Kibel

Book ID: 116947341
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 212 KB
Volume: 69
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.01.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nadir prostate-specific antigen within 1

Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure

✍ Michael E. Ray; Larry B. Levy; Eric M. Horwitz; Patrick A. Kupelian; Alvaro A. M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Prostate-specific antigen versus prostat

Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer

✍ Stephen A. Brassell; Tzu-Cheg Kao; Leon Sun; Judd W. Moul 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Prostate-specific antigen failure within

Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival

✍ TAKAHIKO HACHIYA; TAKETO ICHINOSE; HITOSHI HIRAKATA; NOZOMU KAWATA; KIYOKI OKADA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Posttreatment prostate-specific antigen

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

✍ Alexandra L Hanlon; Hasmik Diratzouian; Gerald E Hanks 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Evaluation of molecular forms of prostat

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy

✍ Sven Wenske; Ruslan Korets; Angel M. Cronin; Andrew J. Vickers; Martin Fleisher; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB 👁 1 views

## Abstract Most pretreatment risk‐assessment models to predict biochemical recurrence (BCR) after radical prostatectomy (RP) for prostate cancer rely on total prostate‐specific antigen (PSA), clinical stage, and biopsy Gleason grade. We investigated whether free PSA (fPSA) and human glandular kall

Prostate cancer volume adds significantl

Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy

✍ Anthony V. D'Amico; Kathleen J. Propert 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 679 KB